Target Name: DNMT1-G9a-PCNA complex
NCBI ID: P18454
Review Report on DNMT1-G9a-PCNA complex Target / Biomarker Content of Review Report on DNMT1-G9a-PCNA complex Target / Biomarker
DNMT1-G9a-PCNA complex
Other Name(s): None

DNMT1-G9a-PCNA Complex Regulates DNA Methylation and Promotes Neurogenesis

The DNMT1-G9a-PCNA complex is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of DNA methylation, a process that plays a crucial role in the development and maintenance of cellular and tissue properties. The DNMT1 gene is often mutated in various diseases, including cancer, and the G9a variant has been shown to have neuroprotective effects. The PCNA protein is a known regulator of DNA methylation and has been shown to interact with the DNMT1 gene.

The DNMT1-G9a-PCNA complex functions as a regulatory unit for DNA methylation in various tissues. When DNA is methylated, the gene is protected from transcription and replication, which can lead to the regulation of gene expression and the development of various diseases. The DNMT1-G9a-PCNA complex is involved in the regulation of DNA methylation at the gene level, and has been shown to play a role in the development of various diseases, including cancer.

One of the key functions of the DNMT1-G9a-PCNA complex is its role in neuroprotection. The DNMT1 gene is often mutated in various neurological and psychiatric diseases, including cancer, and the G9a variant has been shown to have neuroprotective effects. The PCNA protein is a known regulator of DNA methylation and has been shown to interact with the DNMT1 gene. This suggests that the DNMT1-G9a-PCNA complex may play a role in neuroprotection by regulating DNA methylation and promoting neurogenesis.

The DNMT1-G9a-PCNA complex is also involved in the regulation of cellular and tissue homeostasis. The DNMT1 gene is often mutated in various diseases, including cancer, and the G9a variant has been shown to have regulatory functions. The PCNA protein is a known regulator of DNA methylation and has been shown to interact with

Protein Name: DNMT1-G9a-PCNA Complex

The "DNMT1-G9a-PCNA complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNMT1-G9a-PCNA complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DNMT1-HDAC2-DMAP1 complex | DNMT1-Rb-E2F1-HDAC1 complex | DNMT3A | DNMT3AP1 | DNMT3B | DNMT3L | DNPEP | DNPH1 | DNTT | DNTTIP1 | DNTTIP2 | DOC2A | DOC2B | DOC2GP | DOCK1 | DOCK10 | DOCK11 | DOCK2 | DOCK3 | DOCK4 | DOCK4-AS1 | DOCK5 | DOCK6 | DOCK7 | DOCK8 | DOCK8-AS1 | DOCK9 | DOCK9-DT | DOHH | DOK1 | DOK2 | DOK3 | DOK4 | DOK5 | DOK6 | DOK7 | Dolichol-phosphate-mannose synthase complex | DOLK | DOLPP1 | DONSON | DOP1A | DOP1B | Dopamine receptor | DOT1L | Double homeobox protein 4 | DP2-E2F4 complex | DPAGT1 | DPCD | DPEP1 | DPEP2 | DPEP3 | DPF1 | DPF2 | DPF3 | DPH1 | DPH2 | DPH3 | DPH3P1 | DPH5 | DPH5-DT | DPH6 | DPH6-DT | DPH7 | DPM1 | DPM2 | DPM3 | DPP10 | DPP10-AS1 | DPP3 | DPP3-DT | DPP4 | DPP6 | DPP7 | DPP8 | DPP9 | DPP9-AS1 | DPPA2 | DPPA2P3 | DPPA3 | DPPA3P1 | DPPA3P2 | DPPA4 | DPPA4P3 | DPPA5 | DPPA5P4 | DPRX | DPRXP2 | DPRXP4 | DPT | DPY19L1 | DPY19L1P1 | DPY19L2 | DPY19L2P1 | DPY19L2P2 | DPY19L2P3 | DPY19L2P4 | DPY19L3 | DPY19L3-DT | DPY19L4 | DPY30